Antengene Corporation Ltd
HKEX:6996
Antengene Corporation Ltd
Accounts Receivables
Antengene Corporation Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Antengene Corporation Ltd
HKEX:6996
|
Accounts Receivables
¥18.7m
|
CAGR 3-Years
39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Accounts Receivables
¥3.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Accounts Receivables
¥791.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Accounts Receivables
¥6.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
14%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Accounts Receivables
¥10.3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
40%
|
CAGR 10-Years
28%
|
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Accounts Receivables
¥444.6m
|
CAGR 3-Years
29%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Antengene Corporation Ltd
Glance View
Antengene Corp. Ltd. operates as clinical-stage Asia-Pacific biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-11-20. The firm is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. The Company’s products include ATG-010 (selinexor), treating for relapsed/refractory multiple myeloma, relapsed/refractory diffuse large B-cell lymphoma and non-small cell lung cancer and ATG-008 (onatasertib), treating for hepatocellular carcinoma and non-small cell lung cancer. The firm mainly conducts its business in Asia-Pacific.
See Also
What is Antengene Corporation Ltd's Accounts Receivables?
Accounts Receivables
18.7m
CNY
Based on the financial report for Dec 31, 2024, Antengene Corporation Ltd's Accounts Receivables amounts to 18.7m CNY.
What is Antengene Corporation Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 3Y
39%
Over the last year, the Accounts Receivables growth was 93%. The average annual Accounts Receivables growth rates for Antengene Corporation Ltd have been 39% over the past three years .
You don't have any saved screeners yet